208 related articles for article (PubMed ID: 31245174)
21. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer.
Tsujiura M; Komatsu S; Ichikawa D; Shiozaki A; Konishi H; Takeshita H; Moriumura R; Nagata H; Kawaguchi T; Hirajima S; Arita T; Fujiwara H; Okamoto K; Otsuji E
Gastric Cancer; 2015 Apr; 18(2):271-9. PubMed ID: 24626859
[TBL] [Abstract][Full Text] [Related]
22. Plasma
Li B; Zhang H
Int J Clin Exp Pathol; 2017; 10(7):7356-7361. PubMed ID: 31966576
[TBL] [Abstract][Full Text] [Related]
23. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
[TBL] [Abstract][Full Text] [Related]
24. Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer.
Qiu X; Zhang J; Shi W; Liu S; Kang M; Chu H; Wu D; Tong N; Gong W; Tao G; Zhao Q; Qiang F; Zhu H; Wu Q; Wang M; Zhang Z
PLoS One; 2016; 11(3):e0151345. PubMed ID: 27010210
[TBL] [Abstract][Full Text] [Related]
25. Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker.
Wu D; Cao G; Huang Z; Jin K; Hu H; Yu J; Zeng Y
Onco Targets Ther; 2017; 10():129-135. PubMed ID: 28096682
[TBL] [Abstract][Full Text] [Related]
26. [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
Huang SK; Wang J; Li Y; Lin H; Li DD; Cui CJ; Wang GJ; Li XX; Yang L; Zhao M; Huang CZ
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):441-445. PubMed ID: 29936770
[No Abstract] [Full Text] [Related]
27. Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer.
Fu Z; Qian F; Yang X; Jiang H; Chen Y; Liu S
Med Oncol; 2014 Sep; 31(9):164. PubMed ID: 25129310
[TBL] [Abstract][Full Text] [Related]
28. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
Chen Q; Ge X; Zhang Y; Xia H; Yuan D; Tang Q; Chen L; Pang X; Leng W; Bi F
Oncol Rep; 2014 Apr; 31(4):1863-70. PubMed ID: 24481716
[TBL] [Abstract][Full Text] [Related]
29. Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer.
Wu J; Li G; Wang Z; Yao Y; Chen R; Pu X; Wang J
Dis Markers; 2015; 2015():435656. PubMed ID: 26063956
[TBL] [Abstract][Full Text] [Related]
30. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
31. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer.
Zeng W; Zhang S; Yang L; Wei W; Gao J; Guo N; Wu F
BMC Med Genet; 2020 Feb; 21(1):28. PubMed ID: 32041551
[TBL] [Abstract][Full Text] [Related]
32. High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients.
Necula L; Matei L; Dragu D; Pitica I; Neagu AI; Bleotu C; Dima S; Popescu I; Diaconu CC; Chivu-Economescu M
World J Gastroenterol; 2020 Jun; 26(22):3024-3033. PubMed ID: 32587446
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis.
Zhou X; Zhu W; Li H; Wen W; Cheng W; Wang F; Wu Y; Qi L; Fan Y; Chen Y; Ding Y; Xu J; Qian J; Huang Z; Wang T; Zhu D; Shu Y; Liu P
Sci Rep; 2015 Jun; 5():11251. PubMed ID: 26059512
[TBL] [Abstract][Full Text] [Related]
34. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.
Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z
Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer.
Izumi D; Zhu Z; Chen Y; Toden S; Huo X; Kanda M; Ishimoto T; Gu D; Tan M; Kodera Y; Baba H; Li W; Chen J; Wang X; Goel A
JAMA Netw Open; 2021 Aug; 4(8):e2121129. PubMed ID: 34427680
[TBL] [Abstract][Full Text] [Related]
36. Alu-based cell-free DNA: a novel biomarker for screening of gastric cancer.
Qian C; Ju S; Qi J; Zhao J; Shen X; Jing R; Yu J; Li L; Shi Y; Zhang L; Wang Z; Cong H
Oncotarget; 2017 Aug; 8(33):54037-54045. PubMed ID: 28903321
[TBL] [Abstract][Full Text] [Related]
37. Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer.
Huang M; He YR; Liang LC; Huang Q; Zhu ZQ
World J Gastroenterol; 2017 Sep; 23(34):6330-6338. PubMed ID: 28974900
[TBL] [Abstract][Full Text] [Related]
38. Strategies for five tumour markers in the screening and diagnosis of female breast cancer.
Luo J; Xiao J; Yang Y; Chen G; Hu D; Zeng J
Front Oncol; 2022; 12():1055855. PubMed ID: 36755860
[TBL] [Abstract][Full Text] [Related]
39. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
40. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]